The study further found that schizophrenia patients carrying risk alleles of Akt1 and DRD2 genes which influence D2 receptor function had less illness-related reductions in IQ levels with higher doses of antipsychotics than non-risk allele carriers. Here, DRD2 is linked to schizophrenia.